Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

Title
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
Authors
Keywords
Biomarker, Immune-related adverse event, Melanoma, Nivolumab, Overall response rate
Journal
CLINICAL THERAPEUTICS
Volume 41, Issue 1, Pages 59-67
Publisher
Elsevier BV
Online
2018-12-07
DOI
10.1016/j.clinthera.2018.11.004

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More